Metraipolis › archive › dc_9ce7692fac8a

Efficacy of Subconjunctivally Applied Everolimus- and Sirolimus-Pretreated MSCs in Preventing Diabetic Retinopathy — Europe PMC PMID:40952054

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40952054
DOI: 10.1167/tvst.14.9.19
License (as archived): solo-consultazione
Archived: 2026-11-10T05:26:05.044Z
SHA-256 of the archived text: d308e52b0947217f9d0eba90a169cbff28ad47b2d62650fdb2a14a9251be7a8d
Stable URL of this page: https://metraipolis.com/documento/dc_9ce7692fac8a

How to cite

Efficacy of Subconjunctivally Applied Everolimus- and Sirolimus-Pretreated MSCs in Preventing Diabetic Retinopathy — Europe PMC PMID:40952054 — Europe PMC (en), https://europepmc.org/article/MED/40952054 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9ce7692fac8a (Metraipolis archive dc_9ce7692fac8a, sha256 d308e52b0947217f9d0eba90a169cbff28ad47b2d62650fdb2a14a9251be7a8d)

BibTeX

@misc{dc9ce7692fac8a,
  title = {Efficacy of Subconjunctivally Applied Everolimus- and Sirolimus-Pretreated MSCs in Preventing Diabetic Retinopathy — Europe PMC PMID:40952054},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40952054},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9ce7692fac8a; sha256 d308e52b0947217f9d0eba90a169cbff28ad47b2d62650fdb2a14a9251be7a8d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40952054. Agents can read the archived copy with the MCP tool read_document.